← Back to Search

Anthracycline

Radiotherapy for Hodgkin's Lymphoma

Phase 2
Waitlist Available
Led By Monika Metzger, MD
Research Sponsored by St. Jude Children's Research Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient is less than or equal to 21 years of age
Patient has a confirmed diagnosis of previously untreated Hodgkin lymphoma
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5.5 (years) median follow-up with minimum 0.3 to maximum 9.4 years follow-up
Awards & highlights

Study Summary

This trial is testing a new treatment for Hodgkin lymphoma to see if it will help patients live disease-free for three years.

Eligible Conditions
  • Hodgkin's Lymphoma

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5.5 (years) median follow-up with minimum 0.3 to maximum 9.4 years follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5.5 (years) median follow-up with minimum 0.3 to maximum 9.4 years follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
3-year Event-Free Survival Probability
Secondary outcome measures
3-year Event-free Survival (EFS) Probability
3-year Local Failure-free Survival Probability
3-year Overall Survival (OS) Probability
+72 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: All ParticipantsExperimental Treatment10 Interventions
Participants receive 12 weeks of Stanford V chemotherapy which includes Adriamycin®, Vinblastine, Nitrogen Mustard (or Cyclophosphamide), Vincristine, Bleomycin, Etoposide, Prednisone, and G-CSF. After completion of 12 weeks of Stanford V chemotherapy, participants receive radiotherapy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Prednisone
2014
Completed Phase 4
~2370
Radiotherapy
2017
Completed Phase 3
~2610
Vincristine
2003
Completed Phase 4
~2910
Nitrogen Mustard
2006
Completed Phase 2
~90
Etoposide
2010
Completed Phase 3
~2440
Cyclophosphamide
1995
Completed Phase 3
~3780
G-CSF
2014
Completed Phase 4
~1610
Bleomycin
2001
Completed Phase 3
~4960
Adriamycin®
2006
Completed Phase 2
~90
Vinblastine
1998
Completed Phase 3
~5260

Find a Location

Who is running the clinical trial?

St. Jude Children's Research HospitalLead Sponsor
426 Previous Clinical Trials
5,306,524 Total Patients Enrolled
Monika Metzger, MDPrincipal InvestigatorSt. Jude Children's Research Hospital
3 Previous Clinical Trials
421 Total Patients Enrolled
Jamie Flerlage, MDPrincipal InvestigatorSt. Jude Children's Research Hospital
4 Previous Clinical Trials
488 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Mar 2025